Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Americas
A former GSK scientist has pleaded guilty to charges that he conspired to steal trade secrets to benefit a China-based company that he helped establish, according to the US Department of Justice.   17 September 2018
Big Pharma
The European Patent Office has upheld a patent covering Gilead’s hepatitis C medicine sofosbuvir, despite opposition from humanitarian organisation Médecins Sans Frontières.   17 September 2018
Europe
Johnson & Johnson announced this week that its subsidiary J&J Medical has acquired Emerging Implant Technologies (EIT) for an undisclosed amount.   14 September 2018
Big Pharma
Personalised healthcare is a rapidly developing field, not just because of medical advancements, but also because the criteria necessary to secure second medical use patents has similarly evolved over the years, an industry webinar heard.   13 September 2018
Americas
Boston-based Nutter McClennen & Fish has added a team of IP professionals: three partners, two of counsels, one associate, and one technical specialist.   13 September 2018
Americas
Canada-based Bausch Health has agreed to settle all IP litigation with Actavis over antibiotic drug Xifaxan (rifaximin).   13 September 2018
Americas
Generic drug makers Mylan and Teva were afforded victory earlier this week when the US Court of Appeals for the Federal Circuit affirmed the invalidation of four patents owned by biotech company Acorda Therapeutics.   12 September 2018
Americas
Medical device maker Fisher & Paykel Healthcare filed a complaint with the US International Trade Commission yesterday against rival ResMed.   12 September 2018
Americas
The US Court of Appeals for the Federal Circuit yesterday revived a patent infringement lawsuit against Teva Pharmaceuticals, in a win for Sweden-based Orexo.   11 September 2018
Americas
The US Court of Appeals for the Federal Circuit handed a win to the Broad Institute of Harvard and MIT yesterday, after finding that the research institute is entitled to some patents covering CRISPR technology.   11 September 2018